Skip to main content

Table 2 The APACHE (Acute Physiology and Chronic Health Evaluation) III diagnostic groups of the patients

From: Population-based incidence, mortality and quality of life in critically ill patients treated with renal replacement therapy: a nationwide retrospective cohort study in finnish intensive care units

  RRT Non-RRT
Total no. of patients* 1,685 23,208
Non-operative 1,275 (75.7%) 13,782 (59.4%)
Cardiovascular 153 (9.1%) 3,111 (13.4%)
Gastrointestinal 149 (8.8%) 1,338 (5.8%)
Hematological 22 (1.3%) 65 (0.3%)
Metabolic 102 (6.1%) 891 (3.8%)
Neurological 74 (4.4%) 2,423 (10.4%)
Renal 257 (15.3%) 159 (0.7%)
Respiratory 146 (8.7%) 2,572 (11.1%)
Sepsis 284 (16.9%) 1,110 (4.8%)
Trauma 25 (1.5%) 1,115 (4.8%)
Other 44 (2.6%) 661(2.8%)
Missing 19 (1.1%) 337 (1.5%)
Postoperative 410 (24.3%) 9,426 (40.6%)
Cardiovascular 177 (10.5%) 2,947 (12.7%)
Gastrointestinal 137 (8.1%) 2,290 (9.9%)
Gynecological 8 (0.5%) 313 (1.3%)
Neurological 29 (1.7%) 2,060 (8.9%)
Orthopedic 7 (0.4%) 391 (1.7%)
Renal 12 (0.7%) 224 (1.0%)
Respiratory 13 (0.8%) 563 (2.4%)
Trauma 11 (0.7%) 419 (1.8%)
Missing 16 (0.9%) 219 (0.9%)
  1. RRT; renal replacement therapy, non-RRT; patients without renal replacement therapy * Data on APACHE III diagnosis group were missing for one RRT patient and 10 non-RRT patients.